Gofen, 400 mg, caps. №10
- Active ingredient
- Ибупрофен
- Manufacturer
- Mega Lifesciences Public Company Limited
Available in 9 pharmacies
from 24,000 soʻm
Minimum price
from 24,000 soʻm
Gofen instructions for use
The lowest effective dose should be used for the shortest time necessary to relieve symptoms (see section "Features of application").
For oral administration to adults and children over 12 years of age with a body weight > 40 kg. For short-term use only. Undesirable effects can be minimized by using the lowest effective dose for the shortest period of time necessary to control symptoms.
Capsules should be taken preferably during or after meals, not chewed, and washed down with water.
A single dose for children over 12 years of age with a body weight > 40 kg and adults is 1 capsule (400 mg of ibuprofen). If necessary, 1 capsule can be taken every 6 hours. The maximum daily dosage is 1200 mg (3 capsules per day). Use the minimum effective dose necessary to treat symptoms for the shortest period of time.
If symptoms of the disease in adolescents worsen or persist for more than 3 days, it is necessary to consult a doctor to clarify the diagnosis and correct the treatment regimen.
If in adults the elevated body temperature persists for more than 3 days or the pain does not disappear within 4 days or the symptoms of the disease worsen, it is necessary to consult a doctor to clarify the diagnosis and correct the treatment regimen.
The duration of treatment is determined by the doctor individually depending on the course of the disease and the patient's condition.
Elderly patients do not need special dose selection, except in cases of severe renal or hepatic impairment. Due to the possibility of undesirable effects, elderly patients require careful observation.
Patients with mild to moderate renal impairment do not require dose reduction in patients with severe renal impairment. See section "Features of application".
Dose reduction is not required for patients with mild or moderate hepatic impairment in relation to patients with severe renal impairment. See section "Features of application".
Children
Do not use in children under 12 years of age and with a body weight < 40 kg.